BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8485828)

  • 1. Reduction in mortality by pharmacological therapy in congestive heart failure.
    Swedberg K
    Circulation; 1993 May; 87(5 Suppl):IV126-9. PubMed ID: 8485828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R; Kunstmann S; Jalil J
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vasodilator therapy in congestive heart failure. Effects on mortality.
    Greenberg B
    Cardiol Clin; 1994 Feb; 12(1):87-99. PubMed ID: 8181028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic determinants of survival in congestive heart failure. The survival hypothesis: how small uncontrolled studies should influence the design of large-scale clinical trials.
    Francis GS
    Circulation; 1987 May; 75(5 Pt 2):IV74-9. PubMed ID: 3568319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congestive heart failure. Drug therapy: central or peripheral approach?
    Remme WJ
    Cardiologia; 1993 Dec; 38(12 Suppl 1):51-9. PubMed ID: 7912652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic treatment of chronic congestive heart failure].
    Halawa B
    Przegl Lek; 1996; 53(3):119-23. PubMed ID: 8754362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of heart failure. What choice in 1996?].
    Witchitz S; Arsenescu I; Pellerin D
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):445-52. PubMed ID: 8952737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on digoxin therapy in congestive heart failure.
    Haji SA; Movahed A
    Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New medical therapies for advanced left ventricular dysfunction.
    Baughman K
    Cardiol Clin; 1995 Feb; 13(1):27-34. PubMed ID: 7796429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can antiarrhythmic drugs save lives in patients with congestive heart failure?
    Brendorp B; Pedersen OD; Elming H; Køber L; Torp-Pedersen C
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):191-202. PubMed ID: 15030280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.